jueves, 9 de abril de 2020

Roche partners with Arrakis Therapeutics to develop drugs that target RNA

Roche partners with Arrakis Therapeutics to develop drugs that target RNA

Daily Recap

STAT Plus: Roche partners with Arrakis Therapeutics to develop drugs that target RNA

By ADAM FEUERSTEIN


ARRAKIS LAB
Arrakis Therapeutics has signed on its first strategic partner: the Swiss pharma giant Roche. The companies will work to create medicines that target RNA.

No hay comentarios: